Back
Marker Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison
Buy
55
MRKR
Marker Therapeutics
Last Price:
4.07
Seasonality Move:
8.13%
Buy
56
PLX
Protalix BioTherapeutics
Last Price:
1.16
Seasonality Move:
72.04%
Buy
55
Marker Therapeutics (MRKR)
is a Buy
Is Marker Therapeutics a Buy, Sell or Hold?
- The current Marker Therapeutics [MRKR] share price is $4.14. The Score for MRKR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- MRKR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.16. The Score for PLX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MRKR Stock Price Chart
What is Marker Therapeutics's stock price today?
-
The Marker Therapeutics share price today is $4.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRKR is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.16
The current trend is moderately bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
MRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 58.19 | Buy |
| Chaikin Money Flow: | -3590 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3 - 4.26) | Buy |
| Bollinger Bands (100): | (2.96 - 4.84) | Buy |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 53.52 | Buy |
| Chaikin Money Flow: | -161786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.19) | Buy |
| Bollinger Bands (100): | (0.99 - 1.17) | Buy |
MRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.93 | Buy |
| 20-day SMA: | 3.87 | Buy |
| 50-day SMA: | 3.25 | Buy |
| 200-day SMA: | 4.05 | Buy |
| 8-day EMA: | 4 | Buy |
| 20-day EMA: | 3.8 | Buy |
| 50-day EMA: | 3.6 | Buy |
| 200-day EMA: | 3.87 | Buy |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.21 | Sell |
| 20-day SMA: | 1.13 | Buy |
| 50-day SMA: | 1.08 | Buy |
| 200-day SMA: | 1.19 | Sell |
| 8-day EMA: | 1.19 | Sell |
| 20-day EMA: | 1.15 | Buy |
| 50-day EMA: | 1.1 | Buy |
| 200-day EMA: | 1.2 | Sell |
Marker Therapeutics Earnings Growth & MRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Marker Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||